Physiologic control of IDO competence in splenic dendritic cells

Journal of Immunology

Volumn 187, Issue 5, 2011, Pages 2329-2335

  Baban, Babak ^a   Chandler, Phillip R ^a   Johnson III, Burles A ^a   Huang, Lei ^a   Li, Minghui ^a   Sharpe, Marlon L ^a   Francisco, Loise M ^b   Sharpe, Arlene H ^b   Blazar, Bruce R ^c   Munn, David H ^a   Mellor, Andrew L ^a  

^a MEDICAL COLLEGE OF GEORGIA   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN; CD4 ANTIGEN; CPG B OLIGONUCLEOTIDE; CPG C OLIGONUCLEOTIDE; CYTOKINE; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; IMMUNOMODULATING AGENT; INTERLEUKIN 17; INTERLEUKIN 2 RECEPTOR ALPHA; OLIGONUCLEOTIDE; PROGRAMMED DEATH 1 LIGAND 1; PROGRAMMED DEATH 1 RECEPTOR; PROTEIN IDO; REGULATOR PROTEIN; TOLL LIKE RECEPTOR 9; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CD4+ CD25+ T LYMPHOCYTE; CELL INTERACTION; CELLULAR IMMUNITY; CONTROLLED STUDY; DENDRITIC CELL; DOSE RESPONSE; DRUG EFFECT; DRUG MEGADOSE; ENZYME INDUCTION; ENZYME REGULATION; IMMUNE DEFICIENCY; LYMPH NODE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEFECT; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE; SIGNAL TRANSDUCTION; SPLEEN CELL; T LYMPHOCYTE ACTIVATION;

ANIMALS; ANTIGEN PRESENTATION; CELL SEPARATION; DENDRITIC CELLS; FLOW CYTOMETRY; IMMUNOHISTOCHEMISTRY; INDOLEAMINE-PYRROLE 2,3,-DIOXYGENASE; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; OLIGODEOXYRIBONUCLEOTIDES; SPLEEN; T-LYMPHOCYTES, REGULATORY; TOLL-LIKE RECEPTOR 9;

EID: 80052671582     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1100276     Document Type: Article

References (29)

1. Cobbold, S. P., E. Adams, K. F. Nolan, F. S. Regateiro, and H. Waldmann. 2010. Connecting the mechanisms of T-cell regulation: dendritic cells as the missing link. Immunol. Rev. 236: 203-218.
2. Sharpe, A. H. 2009. Mechanisms of costimulation. Immunol. Rev. 229: 5-11.
3. Mellor, A. L., and D. H. Munn. 2008. Creating immune privilege: active local suppression that benefits friends, but protects foes. Nat. Rev. Immunol. 8: 74-80.
4. Munn, D. H., M. D. Sharma, D. Hou, B. Baban, J. R. Lee, S. J. Antonia, J. L. Messina, P. Chandler, P. A. Koni, and A. L. Mellor. 2004. Expression of indoleamine 2,3-dioxygenase by plasmacytoid dendritic cells in tumor-draining lymph nodes. J. Clin. Invest. 114: 280-290. (Pubitemid 39071633)
5. Johnson, B. A., III, D. J. Kahler, B. Baban, P. R. Chandler, B. Kang, M. Shimoda, P. A. Koni, J. Pihkala, B. Vilagos, M. Busslinger, et al. 2010. B-lymphoid cells with attributes of dendritic cells regulate T cells via indoleamine 2,3-dioxygenase. Proc. Natl. Acad. Sci. USA 107: 10644-10648.
6. Sharma, M. D., B. Baban, P. Chandler, D. Y. Hou, N. Singh, H. Yagita, M. Azuma, B. R. Blazar, A. L. Mellor, and D. H. Munn. 2007. Plasmacytoid dendritic cells from mouse tumor-draining lymph nodes directly activate mature Tregs via indoleamine 2,3-dioxygenase. J. Clin. Invest. 117: 2570-2582. (Pubitemid 47494358)
7. Muller, A. J., M. D. Sharma, P. R. Chandler, J. B. Duhadaway, M. E. Everhart, B. A. Johnson, III, D. J. Kahler, J. Pihkala, A. P. Soler, D. H. Munn, et al. 2008. Chronic inflammation that facilitates tumor progression creates local immune suppression by inducing indoleamine 2,3 dioxygenase. Proc. Natl. Acad. Sci. USA 105: 17073-17078.
8. Baban, B., A. M. Hansen, P. R. Chandler, A. Manlapat, A. Bingaman, D. J. Kahler, D. H. Munn, and A. L. Mellor. 2005. A minor population of splenic dendritic cells expressing CD19 mediates IDO-dependent T cell suppression via type I IFN signaling following B7 ligation. Int. Immunol. 17: 909-919. (Pubitemid 41417958)
9. + dendritic cells to acquire potent indoleamine 2,3-dioxygenase- dependent T cell regulatory functions via IFN type 1 signaling. J. Immunol. 175: 5601-5605.
10. Manlapat, A. K., D. J. Kahler, P. R. Chandler, D. H. Munn, and A. L. Mellor. 2007. Cell-autonomous control of interferon type I expression by indoleamine 2,3-dioxygenase in regulatory CD19+ dendritic cells. Eur. J. Immunol. 37: 1064-1071. (Pubitemid 46925342)
11. Mellor, A. L., P. R. Chandler, B. Baban, A. M. Hansen, B. Marshall, J. Pihkala, H. Waldmann, S. P. Cobbold, E. Adams, and D. H. Munn. 2004. Specific subsets of murine dendritic cells acquire potent T cell regulatory functions following CTLA4-mediated induction of indoleamine 2,3 dioxygenase. Int. Immunol. 16: 1391-1401. (Pubitemid 39341552)
12. Francisco, L. M., V. H. Salinas, K. E. Brown, V. K. Vanguri, G. J. Freeman, V. K. Kuchroo, and A. H. Sharpe. 2009. PD-L1 regulates the development, maintenance, and function of induced regulatory T cells. J. Exp. Med. 206: 3015-3029.
13. Fontenot, J. D., J. P. Rasmussen, M. A. Gavin, and A. Y. Rudensky. 2005. A function for interleukin 2 in Foxp3-expressing regulatory T cells. Nat. Immunol. 6: 1142-1151. (Pubitemid 41541792)
14. Baban, B., P. R. Chandler, M. D. Sharma, J. Pihkala, P. A. Koni, D. H. Munn, and A. L. Mellor. 2009. IDO activates regulatory T cells and blocks their conversion into Th17-like T cells. J. Immunol. 183: 2475-2483.
15. Baban, B., P. Chandler, D. McCool, B. Marshall, D. H. Munn, and A. L. Mellor. 2004. Indoleamine 2,3-dioxygenase expression is restricted to fetal trophoblast giant cells during murine gestation and is maternal genome specific. J. Reprod. Immunol. 61: 67-77. (Pubitemid 38446980)
16. Laich, A., G. Neurauter, B. Widner, and D. Fuchs. 2002. More rapid method for simultaneous measurement of tryptophan and kynurenine by HPLC. Clin. Chem. 48: 579-581. (Pubitemid 34174597)
17. Hou, D., A. J. Muller, M. D. Sharma, J. DuHadawy, T. Banerjee, M. Johnson, A. L. Mellor, G. C. Prendergast, and D. H. Munn. 2007. Inhibition of indoleamine 2,3-dioxygenase in dendritic cells by stereoisomers of 1-methyl-tryptophan correlates with antitumor responses. Cancer Res. 67: 792-801. (Pubitemid 46192220)
18. Mellor, A. L., B. Baban, P. Chandler, B. Marshall, K. Jhaver, A. Hansen, P. A. Koni, M. Iwashima, and D. H. Munn. 2003. Cutting edge: induced indoleamine 2,3 dioxygenase expression in dendritic cell subsets suppresses T cell clonal expansion. J. Immunol. 171: 1652-1655. (Pubitemid 36966447)
19. Belladonna, M. L., C. Volpi, R. Bianchi, C. Vacca, C. Orabona, M. T. Pallotta, L. Boon, S. Gizzi, M. C. Fioretti, U. Grohmann, and P. Puccetti. 2008. Cutting edge: Autocrine TGF-b sustains default tolerogenesis by IDO-competent dendritic cells. J. Immunol. 181: 5194-5198.
20. Fallarino, F., U. Grohmann, K. W. Hwang, C. Orabona, C. Vacca, R. Bianchi, M. L. Belladonna, M. C. Fioretti, M. L. Alegre, and P. Puccetti. 2003. Modulation of tryptophan catabolism by regulatory T cells. Nat. Immunol. 4: 1206-1212. (Pubitemid 37547898)
21. Francisco, L. M., P. T. Sage, and A. H. Sharpe. 2010. The PD-1 pathway in tolerance and autoimmunity. Immunol. Rev. 236: 219-242.
22. Yi, H., Y. Zhen, L. Jiang, J. Zheng, and Y. Zhao. 2006. The phenotypic characterization of naturally occurring regulatory CD4+CD25+ T cells. Cell. Mol. Immunol. 3: 189-195.
23. Kryczek, I., S. Wei, L. Zou, G. Zhu, P. Mottram, H. Xu, L. Chen, and W. Zou. 2006. Cutting edge: induction of B7-H4 on APCs through IL-10: novel suppressive mode for regulatory T cells. J. Immunol. 177: 40-44. (Pubitemid 43939113)
24. Johnson, B. A., III, B. Baban, and A. L. Mellor. 2009. Targeting the immunoregulatory indoleamine 2,3 dioxygenase pathway in immunotherapy. Immunotherapy 1: 645-661.
25. Makala, L. H., B. Baban, H. Lemos, A. R. El-Awady, P. R. Chandler, D. Y. Hou, D. H. Munn, and A. L. Mellor. 2011. Leishmania major attenuates host immunity by stimulating local indoleamine 2,3-dioxygenase expression. J. Infect. Dis. 203: 715-725.
26. + regulatory T cells. J. Immunol. 186: 4535-4540.
27. Lund, J. M., L. Hsing, T. T. Pham, and A. Y. Rudensky. 2008. Coordination of early protective immunity to viral infection by regulatory T cells. Science 320: 1220-1224. (Pubitemid 351929511)
28. Vokaer, B., N. Van Rompaey, P. H. Lemaître, F. Lhommé, C. Kubjak, F. S. Benghiat, Y. Iwakura, M. Petein, K. A. Field, M. Goldman, et al. 2010. Critical role of regulatory T cells in Th17-mediated minor antigen-disparate rejection. J. Immunol. 185: 3417-3425.
29. +T cell priming in naive mice. Immunity 33: 942-954.